	US 11,969,451 B2
	Compositions and methods for treating the eye
Wen-Hwa Ting Li, Cranbury, NJ (US); Khalid Mahmood, Lawrenceville, NJ (US); Ramine Parsa, Lawrenceville, NJ (US); Manpreet Randhawa, Robbinsville, NJ (US); Mingqi Bai, Jacksonville, FL (US); and Kenneth T. Holeva, Ponte Vedra Beach, FL (US)
Assigned to Johnson & Johnson Surgical Vision, Inc., Irvine, CA (US)
Filed by Johnson & Johnson Surgical Vision, Inc., Irvine, CA (US)
Filed on Nov. 16, 2020, as Appl. No. 17/099,185.
Claims priority of provisional application 62/937,458, filed on Nov. 19, 2019.
Prior Publication US 2021/0145909 A1, May 20, 2021
Int. Cl. A61K 36/064 (2006.01); A61K 9/08 (2006.01); A61K 9/107 (2006.01); A61K 31/728 (2006.01); A61K 47/02 (2006.01); A61K 47/10 (2017.01); A61K 47/12 (2006.01); A61K 47/26 (2006.01); A61K 47/34 (2017.01); A61K 47/38 (2006.01); A61K 47/46 (2006.01); A61P 27/04 (2006.01)

CPC A61K 36/064 (2013.01) [A61K 9/08 (2013.01); A61K 9/1075 (2013.01); A61K 31/728 (2013.01); A61K 47/02 (2013.01); A61K 47/10 (2013.01); A61K 47/12 (2013.01); A61K 47/26 (2013.01); A61K 47/34 (2013.01); A61K 47/38 (2013.01); A61K 47/46 (2013.01); A61P 27/04 (2018.01)]

13 Claims

1. A microemulsion composition for treating the eye comprising:

i) one or more extracts, of the genus Pichia; and

ii) an ophthalmologically acceptable carrier wherein the microemulsion droplets or particles have a maximum dimension of less than 1,500 Å.